Financial Wire

Apple's Fiscal Q2 Earnings Could Beat Street Consensus, BofA Says

-- Apple's (AAPL) fiscal Q2 earnings could exceed Street estimates on strong iPhone sales, double-digit growth in Services revenue and foreign-exchange tailwinds, BofA Securities said Tuesday in a note.

Upcoming catalysts include a new buyback authorization, the Worldwide Developers Conference in June, the launch of a foldable iPhone in the fall, and the launch of an enhanced Siri integrated with Gemini AI, according to the note.

The brokerage said it expects strong iPhone demand and raised its iPhone unit estimate for fiscal Q2 to 60 million. It models 14% revenue growth for Services, in line with management's guidance.

BofA models fiscal Q2 revenue and earnings per share of $113 billion and $2, respectively, versus Street consensus of $109 billion and $1.93.

The brokerage expects fiscal Q3 revenue and EPS of $106 billion and $1.82, compared with Street consensus of $103 billion and $1.74, respectively.

It also raised its fiscal 2026 revenue and EPS estimates to $466 billion and $8.55 from $462 billion and $8.36.

Apple is scheduled to report fiscal Q2 results on April 30.

BofA maintained a Buy rating on Apple and raised its price target to $325 from $320.

Price: $259.25, Change: $+0.05, Percent Change: +0.02%

相關文章

Treasury

恩智浦半導體贖回7.5億美元2026年到期優先票據

恩智浦半導體(NXPI)週一晚間表示,其子公司恩智浦(NXP)連同恩智浦美國公司(NXP USA)和恩智浦融資公司(NXP Funding)已根據適用契約的條款贖回了7.5億美元未償還的、票面利率為3.875%、將於2026年6月到期的優先票據。

$NXPI
Insider Trading

根據最近提交給美國證券交易委員會(SEC)的文件顯示,Hims & Hers Health 的一位內部人士出售了價值 1,457,305 美元的股票。

財務長 Oluyemi Okupe 於 2026 年 4 月 16 日出售了 Hims & Hers Health (HIMS) 的 54,927 股股票,套現 1,457,305 美元。根據向美國證券交易委員會 (SEC) 提交的 4 號表格文件,奧庫佩目前控制著該公司共計 277,899 股 A 類普通股,其中 270,046 股為直接持有,7,853 股為間接控制。 SEC 文件連結: https://www.sec.gov/Archives/edgar/data/1773751/000190705626000014/xslF345X05/wk-form4_1776717480.xml

$HIMS
Insider Trading

根據最近提交給美國證券交易委員會(SEC)的文件顯示,聯合治療公司(United Therapeutics)內部人士出售了價值5,573,223美元的股票。

2026年4月17日,董事、董事長兼執行長Martine A Rothblatt出售了其持有的United Therapeutics (UTHR) 9,500股股票,套現5,573,223美元。根據向美國證券交易委員會(SEC)提交的4號表格文件,Rothblatt目前控制該公司共計679,797股普通股,其中直接持有40,513股,間接控制639,284股。 SEC文件連結: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000035/xslF345X05/primarydocument.xml

$UTHR